Home

Prosight Management reported a 5.3% stake in Janux Therapeutics JANX · 3,157,220 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
5.3%
Last report
First report
Shares held
3,157,220 sh
Class
Common Stock, $0.001 par value per share
Event date
26/02/03
Filed
26/02/06

First 5%+ report · 5.3% stake

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 01/04~03/05

Prosight Management's other 5% stake reports

  • Prosight Management

    5% stakeOnKure Therapeutics

    2.4% stake

    Filed 08/10

  • Prosight Management

    5% stakeMeiraGTx Holdings

    4% stake

    Filed 02/13

  • Prosight Management

    5% stakeADC Therapeutics

    6.8% stake

    Filed 02/13

  • Prosight Management

    5% stakeOnKure Therapeutics

    5.8% stake

    Filed 25/11/28

Prosight Management reported a 5.3% stake in Janux Therapeutics JANX · 3,157,220 sh · passive holder | Whalegun